Cancer screening adherence among e-cigarette users in the United States
- PMID: 40717811
- PMCID: PMC12290923
- DOI: 10.18332/tpc/207098
Cancer screening adherence among e-cigarette users in the United States
Abstract
Introduction: Tobacco use patterns have dramatically shifted, with electronic cigarettes (e-cigarettes) rapidly increasing in popularity despite uncertainty about their health impacts. This study examines adherence to preventive cancer screening guidelines among cigarette smokers, e-cigarette users, and non-smokers, addressing a critical gap in understanding how tobacco use influences engagement in preventive healthcare.
Methods: A total of 445132 adult respondents were queried from the 2022 Behavioral Risk Factor Surveillance System data. Analytic samples were restricted to age- and sex-eligible sub-cohorts for each cancer type, therefore including adults 50-75 years, women 50-74 years, and women 21-65 years for colon, breast and cervical screening, respectively. Within these analytic samples, we assessed the association between socioeconomic characteristics, smoking status, and screening adherence using weighted logistic regression, adjusted for relevant factors.
Results: Screening adherence was lowest among cigarette smokers, intermediate among e-cigarette users, and highest among non-smokers. Compared to non-smokers, cigarette smokers had significantly lower odds of adhering to colorectal (AOR=0.75; 95% CI: 0.58-0.81), breast (AOR=0.57; 95% CI: 0.52-0.61), and cervical cancer screening (AOR=0.67; 95% CI: 0.62-0.72). E-cigarette users also showed reduced adherence to colorectal (AOR=0.90; 95% CI: 0.81-0.95) and breast cancer screening (AOR=0.75; 95% CI: 0.70-0.81) but not cervical cancer screening.
Conclusions: E-cigarette users exhibited suboptimal adherence to recommended cancer screenings, suggesting that perceptions of reduced risk associated with vaping do not translate into improved preventive healthcare behaviors. Targeted public health initiatives addressing risk misconceptions and healthcare access barriers are necessary to improve screening rates among all tobacco users.
Keywords: BRFSS; cancer screening; e-cigarettes; oncology; smoking status.
© 2025 Mevawalla A. et al.
Conflict of interest statement
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
Figures
Similar articles
-
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590. Health Technol Assess. 2021. PMID: 34668482
-
Heated tobacco products for smoking cessation and reducing smoking prevalence.Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013790. doi: 10.1002/14651858.CD013790.pub2. Cochrane Database Syst Rev. 2022. PMID: 34988969 Free PMC article.
-
Electronic cigarettes for smoking cessation and reduction.Cochrane Database Syst Rev. 2014;(12):CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. Cochrane Database Syst Rev. 2014. PMID: 25515689
-
Interventions to reduce harm from continued tobacco use.Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article.
-
Tobacco smoking and smokeless tobacco use among people living with HIV in Zambia: Findings from a 2023 National NCD/HIV Survey.PLoS One. 2025 Jul 14;20(7):e0327130. doi: 10.1371/journal.pone.0327130. eCollection 2025. PLoS One. 2025. PMID: 40658694 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous